Standigm

Standigm is a drug discovery company that searches for therapeutic lead compounds using advanced artificial intelligence (AI) methods trained on big biomedical data. Standigm has research spans from target identification to drug design for continuous development of commercially valuable medicines. By integrating a platform that identifies new targets & a platform that designs and optimizes new compounds into one continuous flow, Standigm has completed a workflow that can derive the First-in-Class materials (Lead Compounds) within seven months.